Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Linda Cox. (2021) Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy. Expert Review of Clinical Immunology 17:3, pages 255-268.
Read now
Read now
Inês Ribeiro, Francisco Batel Marques, Diogo Mendes & Carlos Alves. (2020) A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities. Ophthalmic Epidemiology 27:5, pages 325-338.
Read now
Read now
José Carlos García Robaina, Carlos Polanco Sánchez & Elvira Estella Pérez. (2016) Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain. ClinicoEconomics and Outcomes Research 8, pages 235-241.
Read now
Read now
Sarah Ronaldson, Matthew Taylor, Peter G Bech, Ruth Shenton & Albrecht Bufe. (2014) Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children. ClinicoEconomics and Outcomes Research 6, pages 187-196.
Read now
Read now
K.Y. Westerhout, B.G. Verheggen, C.H. Schreder & M. Augustin. (2012) Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany. Journal of Medical Economics 15:5, pages 906-917.
Read now
Read now
Articles from other publishers (25)
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen & Marek Jutel. (2022) Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies. Allergy 77:12, pages 3584-3592.
Crossref
Crossref
Barbora Turková, Jan Tužil, Barbora Pilnáčková, Helena Doležalová, Daniela Štrosová, Vít Petrů, Ester Seberová & Tomáš Doležal. (2022) Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic. Immunotherapy 14:14, pages 1109-1120.
Crossref
Crossref
Linda S. Cox, Andrew Murphey & Cheryl Hankin. (2020) The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma. Immunology and Allergy Clinics of North America 40:1, pages 69-85.
Crossref
Crossref
Linda Cox. (2020) Approach to Patients with Allergic Rhinitis. Medical Clinics of North America 104:1, pages 77-94.
Crossref
Crossref
Alson Wai-ming Chan, Wing Pan Luk, Ling Hiu Fung & Tak Hong Lee. (2019) The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions. Immunotherapy 11:16, pages 1387-1397.
Crossref
Crossref
G. Roberts, O. Pfaar, C. A. Akdis, I. J. Ansotegui, S. R. Durham, R. Gerth van Wijk, S. Halken, D. Larenas-Linnemann, R. Pawankar, C. Pitsios, A. Sheikh, M. Worm, S. Arasi, M. A. Calderon, C. Cingi, S. Dhami, J. L. Fauquert, E. Hamelmann, P. Hellings, L. Jacobsen, E. F. Knol, S. Y. Lin, P. Maggina, R. Mösges, J. N. G. Oude Elberink, G. B. Pajno, E. A. Pastorello, M. Penagos, G. Rotiroti, C. B. Schmidt-Weber, F. Timmermans, O. Tsilochristou, E.-M. Varga, J. N. Wilkinson, A. Williams, L. Zhang, I. Agache, E. Angier, M. Fernandez-Rivas, M. Jutel, S. Lau, R. van Ree, D. Ryan, G. J. Sturm & A. Muraro. (2018) EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy 73:4, pages 765-798.
Crossref
Crossref
M. Asaria, S. Dhami, R. van Ree, R. Gerth van Wijk, A. Muraro, G. Roberts & A. Sheikh. (2018) Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview. Allergy 73:2, pages 269-283.
Crossref
Crossref
Sarah K. Wise, Sandra Y. Lin, Elina Toskala, Richard R. Orlandi, Cezmi A. Akdis, Jeremiah A. Alt, Antoine Azar, Fuad M. Baroody, Claus Bachert, G. Walter Canonica, Thomas Chacko, Cemal Cingi, Giorgio Ciprandi, Jacquelynne Corey, Linda S. Cox, Peter Socrates Creticos, Adnan Custovic, Cecelia Damask, Adam DeConde, John M. DelGaudio, Charles S. Ebert, Jean Anderson Eloy, Carrie E. Flanagan, Wytske J. Fokkens, Christine Franzese, Jan Gosepath, Ashleigh Halderman, Robert G. Hamilton, Hans Jürgen Hoffman, Jens M. Hohlfeld, Steven M. Houser, Peter H. Hwang, Cristoforo Incorvaia, Deborah Jarvis, Ayesha N. Khalid, Maritta Kilpeläinen, Todd. T. Kingdom, Helene Krouse, Desiree Larenas-Linnemann, Adrienne M. Laury, Stella E. Lee, Joshua M. Levy, Amber U. Luong, Bradley F. Marple, Edward D. McCoul, K. Christopher McMains, Erik Melén, James W. Mims, Gianna Moscato, Joaquim Mullol, Harold S. Nelson, Monica Patadia, Ruby Pawankar, Oliver Pfaar, Michael P. Platt, William Reisacher, Carmen Rondón, Luke Rudmik, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Russell A. Settipane, Hemant P. Sharma, Aziz Sheikh, Timothy L. Smith, Pongsakorn Tantilipikorn, Jody R. Tversky, Maria C. Veling, De Yun Wang, Marit Westman, Magnus Wickman & Mark Zacharek. (2018) International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. International Forum of Allergy & Rhinology 8:2, pages 108-352.
Crossref
Crossref
S. Dhami, U. Nurmatov, S. Arasi, T. Khan, M. Asaria, H. Zaman, Arnav Agarwal, G. Netuveli, G. Roberts, O. Pfaar, A. Muraro, I. J. Ansotegui, M. Calderon, C. Cingi, S. Durham, R. Gerth Wijk, S. Halken, E. Hamelmann, P. Hellings, L. Jacobsen, E. Knol, D. Larenas‐Linnemann, S. Lin, P. Maggina, R. Mösges, H. Oude Elberink, G. Pajno, R. Panwankar, E. Pastorello, M. Penagos, C. Pitsios, G. Rotiroti, F. Timmermans, O. Tsilochristou, E.‐M. Varga, C. Schmidt‐Weber, J. Wilkinson, A. Williams, M. Worm, L. Zhang & A. Sheikh. (2017) Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis. Allergy 72:11, pages 1597-1631.
Crossref
Crossref
Krupa R. Patel, David J. Phillips, Jason M. Leibowitz, Theresa Scognamiglio, Victoria E. Banuchi, William I. Kuhel, David I. Kutler & Marc A. Cohen. (2016) Value within otolaryngology: Assessment of the cost‐utility analysis literature. World Journal of Otorhinolaryngology - Head and Neck Surgery 2:1, pages 28-37.
Crossref
Crossref
Marek Jutel, Ioana Agache, Sergio Bonini, A. Wesley Burks, Moises Calderon, Walter Canonica, Linda Cox, Pascal Demoly, Antony J. Frew, Robyn O'Hehir, Jörg Kleine-Tebbe, Antonella Muraro, Gideon Lack, Désirée Larenas, Michael Levin, Bryan L. Martin, Harald Nelson, Ruby Pawankar, Oliver Pfaar, Ronald van Ree, Hugh Sampson, James L. Sublett, Kazunari Sugita, George Du Toit, Thomas Werfel, Roy Gerth van Wijk, Luo Zhang, Mübeccel Akdis & Cezmi A. Akdis. (2016) International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. Journal of Allergy and Clinical Immunology 137:2, pages 358-368.
Crossref
Crossref
Jørgen Nedergaard Larsen, Louise Broge & Henrik Jacobi. (2016) Allergy immunotherapy: the future of allergy treatment. Drug Discovery Today 21:1, pages 26-37.
Crossref
Crossref
Linda Cox. (2015) Allergy immunotherapy in reducing healthcare cost. Current Opinion in Otolaryngology & Head and Neck Surgery 23:3, pages 247-254.
Crossref
Crossref
Bram G Verheggen, Kirsten Y Westerhout, Carl H Schreder & Matthias Augustin. (2015) Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass‐allergic rhinoconjunctivitis in Germany. Clinical and Translational Allergy 5:1, pages 1.
Crossref
Crossref
Cheryl S. Hankin & Linda Cox. (2014) Allergy immunotherapy. Current Opinion in Allergy & Clinical Immunology 14:4, pages 363-370.
Crossref
Crossref
Janine Biermann, Hans F. Merk, Wolfgang Wehrmann, Ludger Klimek & Jürgen Wasem. (2013) Allergic disorders of the respiratory tract — findings from a large patient sample in the German statutory health insurance systemAllergische Erkrankungen der Atemwege — Ergebnisse einer umfassenden Patientenkohorte in der deutschen gesetzlichen Krankenversicherung. Allergo Journal 22:6, pages 366-373.
Crossref
Crossref
Oliver Pfaar, Hendrik Wolf, Ludger Klimek, Jörg Schnitker & Eike Wüstenberg. (2012) Immunologic Effect and Tolerability of Intra-Seasonal Subcutaneous Immunotherapy With an 8-Day Up-Dosing Schedule to 10,000 Standardized Quality-Units: A Double-Blind, Randomized, Placebo-Controlled Trial. Clinical Therapeutics 34:10, pages 2072-2081.
Crossref
Crossref
S. Simoens. (2012) The cost‐effectiveness of immunotherapy for respiratory allergy: a review. Allergy 67:9, pages 1087-1105.
Crossref
Crossref
Linda Cox & Dana Wallace. (2011) Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and Sublingual. Immunology and Allergy Clinics of North America 31:3, pages 561-599.
Crossref
Crossref
Cheryl S. Hankin, Linda Cox & Amy Bronstone. (2011) The Health Economics of Allergen Immunotherapy. Immunology and Allergy Clinics of North America 31:2, pages 325-341.
Crossref
Crossref
Richard F. Lockey & Cheryl S. Hankin. (2011) Health economics of allergen-specific immunotherapy in the United States. Journal of Allergy and Clinical Immunology 127:1, pages 39-43.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:6, pages 590-596.
Crossref
Crossref
Patrizia Berto, Franco Frati & Cristoforo Incorvaia. (2008) Economic studies of immunotherapy: a review. Current Opinion in Allergy & Clinical Immunology 8:6, pages 585-589.
Crossref
Crossref
Jitka Pokladnikova, Irena Krcmova & Jiri Vlcek. (2008) Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Annals of Allergy, Asthma & Immunology 100:5, pages 482-489.
Crossref
Crossref
. (2013) Grass pollen extract not to be sneezed at for SAR. PharmacoEconomics & Outcomes News 533:1, pages 8-8.
Crossref
Crossref